CAPLIN POINT LABORATORIES
Live / Applied — Statement of use — final refusal mailed (as of 26 May 2026)
What this means for you
Not registered yet, but its 24 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98148403
- Mark type
- Design + words
- Filed
- 24 Aug 2023
- Published for opposition
- 25 Mar 2025
- Attorney of record
- Touhey Myer
Goods and services
- Class 005 — Pharmaceuticals: Ophthalmic preparations
- Class 035 — Advertising and business services: Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences
Owner
- Caplin Point Laboratories Limited, Chennai, IN
- Caplin Point Laboratories Limited, Chennai, IN
Prosecution history
- 24 Aug 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 24 Aug 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 26 May 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 26 May 2026 — FINAL REFUSAL E-MAILED
- 26 May 2026 — SU - FINAL REFUSAL - WRITTEN
- 21 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 May 2026 — ASSIGNED TO LIE
- 19 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Feb 2026 — NON-FINAL ACTION E-MAILED
- 19 Feb 2026 — SU - NON-FINAL ACTION - WRITTEN
- 24 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Jul 2025 — USE AMENDMENT FILED
- 24 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL